What are the efficacy and safety considerations in using ponatinib?

Dr. Karen Seiter discusses the efficacy and safety considerations in using ponatinib.

For more information, tools, resources and CE activities please http://managingcml.com/

Managing CML is an educational online community for health care professionals who provide care to patients with chronic myelogenous leukemia, or CML. Our mission is to provide ongoing evidence-based scientific data and the most up-to-date information, tools, and resources for treating this hematologic malignancy in your clinical practice.